CRON
Cronos Group Inc. [CRON] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRON Stock Summary
Top 10 Correlated ETFs
CRON
Top 10 Correlated Stocks
CRON
CRON Financial details
Company Rating
Neutral
Market Cap
656.43M
Income
-155.34M
Revenue
87.02M
Book val./share
2.97
Cash/share
2.2
Dividend
-
Dividend %
-
Employees
447
Optionable
Yes
Shortable
Yes
Earnings
07 Aug 2023
P/E
-4.09
Forward P/E
-
PEG
0.67
P/S
7.54
P/B
0.56
P/C
0.76
P/FCF
-6.09
Quick Ratio
29.66
Current Ratio
31.45
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-0.41
EPS next Y
-
EPS next Q
-0.06
EPS this Y
-57.94%
EPS next Y
-
EPS next 5Y
26.12%
EPS last 5Y
40.6%
Revenue last 5Y
51.46%
Revenue Q/Q
-11.98%
EPS Q/Q
-75.9%
-
-
-
-
SMA20
-7.98%
SMA50
-9.9%
SMA100
-31.08%
Inst Own
10.08%
Inst Trans
0.69%
ROA
-13%
ROE
-13%
ROC
-0.1%
Gross Margin
9%
Oper. Margin
-125%
Profit Margin
-179%
Payout
-
Shs Outstand
393.07M
Shs Float
202.73M
-
-
-
-
Target Price
4
52W Range
1.66-3.616
52W High
-44%
52W Low
+68%
RSI
39.18
Rel Volume
0.66
Avg Volume
1.18M
Volume
784.56K
Perf Week
-4%
Perf Month
-8.7%
Perf Quarter
-40%
Perf Half Y
-41.87%
-
-
-
-
Beta
1.41916
-
-
Volatility
0.03%, 0.09%
Prev Close
-1.18%
Price
1.68
Change
-3.45%
CRON Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.07 | 0 | 0.13 | 0.2 | 0.24 | |
| Net income per share | -0.08 | 0 | -0.21 | -1.07 | -0.45 | |
| Operating cash flow per share | -0.04 | 0 | -0.41 | -0.41 | -0.24 | |
| Free cash flow per share | -0.53 | 0 | -0.51 | -0.45 | -0.25 | |
| Cash per share | 0.14 | 0 | 3.67 | 2.71 | 2.33 | |
| Book value per share | 0.9 | 0 | 4.87 | 3.61 | 3.03 | |
| Tangible book value per share | 0.85 | 0 | 4.15 | 3.55 | 2.95 | |
| Share holders equity per share | 0.9 | 0 | 4.87 | 3.61 | 3.03 | |
| Interest debt per share | 0.09 | 0 | 0.03 | 0.03 | 0.07 | |
| Market cap | 2.44B | 0 | 3.11B | 1.85B | 1.3B | |
| Enterprise value | 2.43B | -1.19B | 2.04B | 973.23M | 535.47M | |
| P/E ratio | -172.92 | 0 | -41.69 | -4.66 | -7.68 | |
| Price to sales ratio | 211.48 | 0 | 66.59 | 24.86 | 14.1 | |
| POCF ratio | -340.99 | 0 | -21.84 | -12.05 | -14.57 | |
| PFCF ratio | -26.67 | 0 | -17.49 | -11.16 | -13.79 | |
| P/B Ratio | 15.7 | 0 | 1.82 | 1.38 | 1.13 | |
| PTB ratio | 15.7 | 0 | 1.82 | 1.38 | 1.13 | |
| EV to sales | 210.74 | -50.21 | 43.73 | 13.07 | 5.83 | |
| Enterprise value over EBITDA | -209.19 | 0.85 | -12.76 | 43.87 | -9.05 | |
| EV to operating cash flow | -339.79 | 9.17 | -14.34 | -6.34 | -6.02 | |
| EV to free cash flow | -26.58 | 7.06 | -11.49 | -5.87 | -5.7 | |
| Earnings yield | -0.01 | 0 | -0.02 | -0.21 | -0.13 | |
| Free cash flow yield | -0.04 | 0 | -0.06 | -0.09 | -0.07 | |
| Debt to equity | 0.1 | 0 | 0.01 | 0.01 | 0 | |
| Debt to assets | 0.08 | 0 | 0.01 | 0.01 | 0 | |
| Net debt to EBITDA | 0.74 | 0.85 | 6.67 | -39.54 | 12.85 | |
| Current ratio | 1.43 | 4.72 | 6.63 | 19.86 | 14.1 | |
| Interest coverage | -169.23 | 0 | -964.23 | 251.3 | -5.15 | |
| Income quality | 0.51 | -0.11 | 1.89 | 0.39 | 0.53 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 1.38 | 2.57 | 2.05 | 1.43 | 0.94 | |
| Research and developement to revenue | 0.15 | 0.51 | 0.44 | 0.31 | 0.15 | |
| Intangibles to total assets | 0.05 | 0.14 | 0.13 | 0.01 | 0.02 | |
| Capex to operating cash flow | 11.78 | 0.3 | 0.25 | 0.08 | 0.06 | |
| Capex to revenue | -7.31 | -1.64 | -0.76 | -0.16 | -0.05 | |
| Capex to depreciation | -45.72 | -9.95 | -5.02 | -0.8 | -0.38 | |
| Stock based compensation to revenue | 0.27 | 0.49 | 0.33 | 0.14 | 0.16 | |
| Graham number | 1.29 | 0 | 4.82 | 9.33 | 5.53 | |
| ROIC | -0.1 | 1.13 | 0.67 | -0.02 | 0.44 | |
| Return on tangible assets | -0.08 | 2.07 | -0.04 | -0.29 | -0.14 | |
| Graham Net | 0 | 0 | 3.17 | 2.65 | 2.26 | |
| Working capital | 14.37M | 1.24B | 1.17B | 1.03B | 892.04M | |
| Tangible asset value | 145.82M | 1.46B | 1.46B | 1.32B | 1.11B | |
| Net current asset value | 11.44M | 1.23B | 1.15B | 1.02B | 888.11M | |
| Invested capital | 0.1 | 0 | 0.01 | 0.01 | 0 | |
| Average receivables | 4.71M | 11.17M | 21.29M | 29.67M | 35.53M | |
| Average payables | 8.83M | 23.35M | 38.7M | 26.66M | 11.19M | |
| Average inventory | 12.41M | 26.61M | 41.02M | 38.4M | 35.18M | |
| Days sales outstanding | 183.53 | 254.1 | 203.47 | 163.25 | 150 | |
| Days payables outstanding | 1.28K | 309.63 | 211.81 | 44.52 | 50.97 | |
| Days of inventory on hand | 1.7K | 333.68 | 221.37 | 130.18 | 171.5 | |
| Receivables turnover | 1.99 | 1.44 | 1.79 | 2.24 | 2.43 | |
| Payables turnover | 0.29 | 1.18 | 1.72 | 8.2 | 7.16 | |
| Inventory turnover | 0.21 | 1.09 | 1.65 | 2.8 | 2.13 | |
| ROE | -0.09 | 2.14 | -0.04 | -0.3 | -0.15 | |
| Capex per share | -0.49 | 0 | -0.1 | -0.03 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | |
| Net income per share | -0.09 | -0.05 | -0.1 | -0.21 | -0.05 | |
| Operating cash flow per share | -0.09 | -0.05 | -0.04 | -0.06 | -0.13 | |
| Free cash flow per share | -0.09 | -0.05 | -0.04 | -0.07 | -0.13 | |
| Cash per share | 2.62 | 2.51 | 2.35 | 2.32 | 2.2 | |
| Book value per share | 3.53 | 3.43 | 3.16 | 3.03 | 2.97 | |
| Tangible book value per share | 3.47 | 3.35 | 3.09 | 2.94 | 2.89 | |
| Share holders equity per share | 3.53 | 3.43 | 3.16 | 3.03 | 2.97 | |
| Interest debt per share | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | |
| Market cap | 1.82B | 1.36B | 1.46B | 1.3B | 998.5M | |
| Enterprise value | 971.29M | 575.13M | 831.69M | 539.44M | 588.36M | |
| P/E ratio | -13.96 | -16.67 | -9.88 | -4.12 | -12.96 | |
| Price to sales ratio | 72.85 | 58.79 | 69.69 | 56.81 | 49.57 | |
| POCF ratio | -53.77 | -78.46 | -108.93 | -53.35 | -20.94 | |
| PFCF ratio | -52.64 | -70.67 | -97.14 | -51.72 | -20.59 | |
| P/B Ratio | 1.38 | 1.05 | 1.22 | 1.14 | 0.88 | |
| PTB ratio | 1.38 | 1.05 | 1.22 | 1.14 | 0.88 | |
| EV to sales | 38.8 | 24.94 | 39.75 | 23.57 | 29.21 | |
| Enterprise value over EBITDA | -44.87 | -25.49 | -47.94 | -1.21K | -58.11 | |
| EV to operating cash flow | -28.64 | -33.28 | -62.14 | -22.13 | -12.34 | |
| EV to free cash flow | -28.04 | -29.98 | -55.41 | -21.46 | -12.13 | |
| Earnings yield | -0.02 | -0.02 | -0.03 | -0.06 | -0.02 | |
| Free cash flow yield | -0.02 | -0.01 | -0.01 | -0.02 | -0.05 | |
| Debt to equity | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Net debt to EBITDA | 39.37 | 34.6 | 36.11 | 1.71K | 40.51 | |
| Current ratio | 26.42 | 26.18 | 25.37 | 14.1 | 31.45 | |
| Interest coverage | -14.4 | -7.1 | -4.23 | -3.13 | -2.72 | |
| Income quality | 1.04 | 0.85 | 0.36 | 0.31 | 2.48 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 1.04 | 0.85 | 1.02 | 0.84 | 0.74 | |
| Research and developement to revenue | 0.16 | 0.19 | 0.12 | 0.11 | 0.1 | |
| Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | 0.02 | 0.11 | 0.12 | 0.03 | 0.02 | |
| Capex to revenue | -0.03 | -0.08 | -0.08 | -0.03 | -0.04 | |
| Capex to depreciation | -0.26 | -0.45 | -0.47 | -0.29 | -0.33 | |
| Stock based compensation to revenue | 0.15 | 0.11 | 0.2 | 0.2 | 0.13 | |
| Graham number | 2.63 | 2.04 | 2.63 | 3.77 | 1.84 | |
| ROIC | 0.08 | 0.1 | 0.83 | 0.15 | -0.06 | |
| Return on tangible assets | -0.02 | -0.02 | -0.03 | -0.07 | -0.02 | |
| Graham Net | 2.6 | 2.5 | 2.34 | 2.26 | 2.22 | |
| Working capital | 1.02B | 986.86M | 925.34M | 892.04M | 887.01M | |
| Tangible asset value | 1.3B | 1.26B | 1.17B | 1.11B | 1.1B | |
| Net current asset value | 1.01B | 978.8M | 917.08M | 888.11M | 882.96M | |
| Invested capital | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Average receivables | 34.32M | 32.25M | 30.37M | 34.67M | 32.62M | |
| Average payables | 11.06M | 11.68M | 11.22M | 10.58M | 12M | |
| Average inventory | 34.93M | 38.45M | 36.97M | 35.83M | 40.91M | |
| Days sales outstanding | 127.08 | 113.81 | 135.81 | 148.53 | 122.75 | |
| Days payables outstanding | 54.2 | 59.15 | 45.48 | 43.45 | 65.06 | |
| Days of inventory on hand | 184.18 | 189.31 | 155.24 | 146.2 | 224.28 | |
| Receivables turnover | 0.71 | 0.79 | 0.66 | 0.61 | 0.73 | |
| Payables turnover | 1.66 | 1.52 | 1.98 | 2.07 | 1.38 | |
| Inventory turnover | 0.49 | 0.48 | 0.58 | 0.62 | 0.4 | |
| ROE | -0.02 | -0.02 | -0.03 | -0.07 | -0.02 | |
| Capex per share | 0 | -0.01 | 0 | 0 | 0 |
CRON Frequently Asked Questions
What is Cronos Group Inc. stock symbol ?
Cronos Group Inc. is a CA stock , located in Toronto of On and trading under the symbol CRON
Is Cronos Group Inc. buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $4. The lowest prediction is $3.5 and the highest is $4.5
What is CRON stock prediction ?
What is Cronos Group Inc. stock quote today ?
Cronos Group Inc. stock price is $1.68 today.
Is Cronos Group Inc. stock public?
Yes, Cronos Group Inc. is a publicly traded company.
Company Profile
- Volume Average 1.18M
- Market Capitalization 656.43M
- Employee 447
- CEO Mr. Michael Ryan Gorenstein J.D.
- Headquarters Toronto,ON,CA
- IPO Date 2014-05-07
-
Website
https://www.thecronosgroup.com 
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
